|
PrimeCell Therapeutics LLC (Irvine, Calif.) said on June 27 that it provided research support and pre-clinical studies for a clinical trial to assess the safety, feasibility and efficacy of implanting autologous bone marrow stem cells into spinal cord injury (SCI) patients.
Dr. Luis Geffner presented a preliminary report at a meeting of the International Society for Cellular Therapy last month in Australia.
From May 2006 to January 2007, 25 patients with SCI were treated at Luis Vernaza Hospital in Guayaquil, Ecuador.
They were treated with autologous bone marrow stem cells, meaning the cells were extracted from the patients’ own bone marrow.
Fifteen patients (60 percent) could stand up, ten patients (40 percent) could walk on the parallels with braces, seven (28 percent) could walk without braces, and four (16 percent) could walk with crutches.
Patients demonstrated improvements in sensitivity, motility, bladder sensation, even controlling sphincters, erection and ejaculation. No adverse event was observed.
“These preliminary results, while encouraging, must be interpreted cautiously and prudently, and we must continue work examining the benefits of surgically implanted autologous bone marrow stem cells to patients with spinal cord injuries,” said Geffner, director of the stem cell program at the Junta de Beneficencia de Guayaquil.
Pre-clinical studies were performed by stem cell biologist and senior author Francisco Silva and his team at PrimeCell Therapeutics, based in Irvine, Calif.
The study included in vitro (laboratory tests), pre-clinical (animal) and clinical (human) data.
“There is evidence demonstrating significant improvement in the quality of life of patients receiving the treatment, including spinal cord regeneration and additional clinical improvements following these stem cell transplants,” said Silva, vice president of research and development for PrimeCell Therapeutics. “More research is needed, of course, but this is very encouraging. Our ultimate goal, as always, is not just research - but research that will lead to timely viable therapies.”
PrimeCell is devoted exclusively to germ line stem cell reprogramming.
Its next generation stem cell, PrimeCell, is an adult stem cell derived from the germ line and reprogrammed to exhibit pluripotency.
Contact: http://www.primecelltherapeutics.com
...
Citation: (Article name, authors,
publication, DOI)
Article or Abstract: (link)
Contact: (link)
Start a free one-week trial
subscription to StemCellResearchNews.com to access
ALL premium
content on this Web site.
Read about research you won't hear about on the nightly news or
on Google.
Click here. (See below for information on why Premium Content is
really worth
it.)
Get the whole story: article citations, links
to further information, links to journal abstract pages, related
articles, researcher contact information, etc.
Or ...
Subscribe
to Stem Cell Lab World, Stem Cell Research News,
Stem Cell Business News for complete access PLUS biweekly
e-mail delivery of a PDF publication you can save on your
computer or print and store in a binder.
FAQ: Why do you charge to read Premium Content ($) articles?
For many years we have provided stem cell-related news and
analysis free of charge on this Web Site, supported by
advertising and subscription income. Unfortunately, in today’s
economy, advertising placements are at an all-time low. That has
forced us (and other publishers) to seek income elsewhere.
Hence, the subscription fees for premium content.
FAQ: What makes Premium Content articles worth the price?
There are seven key reasons:
1) You read about stem cell research you'll never hear about
in the general press, and you'll get the complete article, not just a snippet.
2) Important references are clickable links. (e.g., a
reference to a research institution
or researcher's lab site or more
information about a disease or disorder
are highlighted and clickable as Web links.)
3) Full citations are provided for all journal articles
so you can access the original research.
4) Links to article abstracts are provided.
5) Links to researcher e-mail addresses and lab Web sites
are provided whenever available.
6) Graphic images are provided when available.
7) Links to Related Articles in our database of more than
2,000 stem cell research articles.
Subscribe now!
Click here
to subscribe to a newsletter (including biweekly delivery of PDF
editions PLUS Web site Premium Content) or
click here to
subscribe to the Web site Premium Content only.
 |
